# Co-administration of IVM and ALB in School-based Deworming in Uganda

> **NCT06497075** · — · COMPLETED · sponsor: **Jennifer Keiser** · enrollment: 8767 (actual)

## Conditions studied

- Helminthiasis
- Intestinal Worms

## Interventions

- **DRUG:** Albendazole 400mg
- **DRUG:** Ivermectin 3 MG

## Key facts

- **NCT ID:** NCT06497075
- **Lead sponsor:** Jennifer Keiser
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2024-07-16
- **Final completion:** 2024-10-19
- **Target enrollment:** 8767 (ACTUAL)
- **Last updated:** 2024-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497075, "Co-administration of IVM and ALB in School-based Deworming in Uganda". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06497075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*